Early Online
Open Access DOI:10.23937/2378-3001/1410127
The Utility of IVIG in the Management of Autoimmune Encephalitis: A Retrospective Case Series
Katherine Frustaci, BS, Natasha Qutab, MD and Svetlana Eckert, MD
Article Type: Case Series | Indexed Archive: Volume 11
Autoimmune encephalitis (AE) involves inflammation of the brain parenchyma due to autoantibodies targeting neuronal cell surfaces or synaptic proteins [1]. It is a rapidly progressive disorder and can lead to significant morbidity, prolonged hospital stays, and possible mortality. Intravenous immunoglobulin (IVIG) is a treatment for AE that may be used when other acute treatments are ineffective or contraindicated. It has been proven useful in many autoimmune disorders [2-5], though is underutil...
Article Formats
- Full Article
- XML
- EPub Reader
Open Access DOI:10.23937/2378-3001/1410126
Effects of Galactooligosaccharides on the Gut Microbiome in Patients with Alzheimer's Dementia
Georg Adler and Agnieszka Marczak
Article Type: Brief Report | Indexed Archive: Volume 11
Alterations of the gut microbiome may accelerate the course of Alzheimer's dementia through the enhancement of inflammatory and neurodegenerative processes. Prebiotic galactooligosaccharides increase the abundance of Bifidobacterium species and may have beneficial effects on disease progression....
Article Formats
- Full Article
- XML
- EPub Reader
Volume 11
Issue 1
Issue 1